Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (476)
Cancellation by sponsor (195)
Cancellation or suspension (77)
Prescription medicine registration (37)
Cancellation for failure to pay annual charge (17)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2024 (73)
2023 (102)
2022 (74)
2021 (76)
2020 (120)
2019 (22)
2018 (69)
2017 (106)
2016 (31)
2015 (36)
2014 (21)
2013 (9)
2012 (5)
2011 (6)
2010 (20)
2009 (5)
2008 (3)
2007 (6)
2006 (7)
2005 (2)
2004 (2)
2003 (4)
2002 (3)
2001 (4)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Results for "[search-keyword]"

Search

Sponsor content

811 result(s) found, displaying 531 to 540

PULMORIS ambrisentan 10 mg tablet blister pack (282337)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PULMORIS ambrisentan 10 mg tablet blister pack.
PULMORIS ambrisentan 5 mg tablet blister pack (282338)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PULMORIS ambrisentan 5 mg tablet blister pack.
CIPLA AMBRISENTAN ambrisentan 10 mg tablet blister pack (282339)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA AMBRISENTAN ambrisentan 10 mg tablet blister pack.
CIPLA AMBRISENTAN ambrisentan 5 mg tablet blister pack (282340)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA AMBRISENTAN ambrisentan 5 mg tablet blister pack.
SANDOZ LAMOTRIGINE lamotrigine 100mg tablet blister pack (291471)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SANDOZ LAMOTRIGINE lamotrigine 100mg tablet blister pack.
SANDOZ LAMOTRIGINE lamotrigine 200mg tablet blister pack (291472)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SANDOZ LAMOTRIGINE lamotrigine 200mg tablet blister pack.
ATAZANAVIR CIPLA atazanavir 150 mg capsule blister pack (275395)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 150 mg capsule blister pack.
ATAZANAVIR CIPLA atazanavir 150 mg capsule bottle pack (276184)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 150 mg capsule bottle pack.
ATAZANAVIR CIPLA atazanavir 200 mg capsule blister pack (276189)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 200 mg capsule blister pack.
ATAZANAVIR CIPLA atazanavir 200 mg capsule bottle pack (276191)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 200 mg capsule bottle pack.

Pages

First page
Previous page
…
Page 50
Page 51
Page 52
Page 53
Current page 54
Page 55
Page 56
Page 57
Page 58
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.